DrugPatentWatch Database Preview
Drugs in Development Information for Tocotrienol
Drug Development Status for Tocotrienol: Patents, clinical trial progress, indications
Tocotrienol is an investigational drug.
There have been 17 clinical trials for Tocotrienol.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Ovarian Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are Vejle Hospital, National Cancer Institute (NCI), and H. Lee Moffitt Cancer Center and Research Institute.
There are thirty-one US patents protecting this investigational drug and one hundred and ninety-eight international patents.
Summary for Tocotrienol
| US Patents | 31 |
| International Patents | 198 |
| US Patent Applications | 46 |
| WIPO Patent Applications | 22 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 0 |
Recent Clinical Trials for Tocotrienol
| Title | Sponsor | Phase |
|---|---|---|
| Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation | INSTITUT JANTUNG NEGARA | Phase 2/Phase 3 |
| Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation | Monash University Malaysia | Phase 2/Phase 3 |
| Tocotrienols for Obesity of Postmenopausal Women | Texas Tech University Health Sciences Center | Phase 1/Phase 2 |
Clinical Trial Summary for Tocotrienol
Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol
US Patents for Tocotrienol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Tocotrienol | See Pricing | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (New York, NY) | See Pricing |
| Tocotrienol | See Pricing | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (New York, NY) | See Pricing |
| Tocotrienol | See Pricing | Antioxidant compositions for coating substrates, substrates coated with the same and methods for inhibiting the oxidation of such compositions applied to a substrate | PPG Industries, Inc. (Pittsburgh, PA) | See Pricing |
| Tocotrienol | See Pricing | Substrates coated with antioxidant compositions and method for inhibiting the oxidation of such compositions applied to a substrate | PPG Industries, Inc. (Pittsburgh, PA) | See Pricing |
| Tocotrienol | See Pricing | Stabilizer in solid form for organic polymers | Great Lakes Chemical (Europe) GmbH (Fraunfeld, CH) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Tocotrienol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Tocotrienol | Canada | 2026713 | 2009-10-04 | See Pricing |
| Tocotrienol | European Patent Office | 0421419 | 2009-10-04 | See Pricing |
| Tocotrienol | Hungary | 207442 | 2009-10-04 | See Pricing |
| Tocotrienol | Hungary | 906297 | 2009-10-04 | See Pricing |
| Tocotrienol | Hungary | T54887 | 2009-10-04 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
